Skip to main content
. 2014 May 28;12(6):3203–3217. doi: 10.3390/md12063203

Figure 3.

Figure 3

The evaluation of toxicity of clavatustide B by comparison of cell viability curves between normal human fibroblasts and cancer cell lines after 24 h (A); 48 h (B) and 72 h (C) treatments.